BritePear› 🍐 Peptide You› 🍐 Seed to Harvest
Peptide You · How to Evaluate Any Claim

🍐 Seed to Harvest: How a Compound Gets to You

The plain English framework for understanding the path from lab bench to patient, so you can evaluate any peptide claim you encounter.

🍐 Pear It Down ,

Before you can evaluate a claim about any peptide or GLP-1 compound, you need to understand the pathway it's supposed to have traveled. Most haven't gone the full distance. Here's the four-phase FDA trial pathway in plain English, the three sourcing tiers you'll actually encounter, and why "Research Use Only" is a legal posture, not a safety rating.

Not medical advice. This is educational information for context and informed decision-making. Nothing here constitutes medical advice or a recommendation to pursue any specific compound. All decisions should be made in consultation with a qualified healthcare provider.

I built this page because I got tired of reading peptide content that assumed you already knew what "Phase II trial" meant, or why it matters whether an API came from China or a domestic facility. You shouldn't have to already know the system to evaluate the claims being made inside it.

This is the framework. Every peptide you encounter in Peptide You maps somewhere onto this. Knowing where it sits changes how you read everything else.

The FDA Trial Pathway

Four Phases, What Each One Actually Means

Phase I, Is It Safe in Humans?

Small group of healthy volunteers. The question is not "does it work?", it's "does it hurt anyone?" Researchers establish safe dose ranges and document how the body processes the compound. Most investigational peptides that have any human data are at Phase I.

Phase II, Does It Work? In Whom?

A few hundred patients with the target condition. Researchers are now asking whether the compound produces the intended effect, finding the right dose, and watching for side effects. Phase II data is real clinical data, it's the evidence base for most peptides you'll read about that have "human research" behind them.

Phase III, Does It Work at Scale?

Thousands of patients across multiple sites. Randomized controlled trial. This is where the STEP trials (semaglutide) and SURMOUNT trials (tirzepatide) happened. Phase III is the proof. Most peptides discussed in Peptide You have not reached Phase III for their claimed use.

FDA Approval + cGMP Manufacturing

The NDA is submitted, FDA reviewers evaluate all trial data, and if approved, the compound can be manufactured at scale under cGMP standards and marketed for its approved indication. Ozempic, Wegovy, Mounjaro, and Zepbound have made this journey. Most peptides in the gray market space have not.

The Sourcing Tiers

Where It Actually Comes From

Tier 1, Pharmaceutical GradeFDA-approved drug manufactured by a licensed pharmaceutical company, OR compounded by a state-licensed, FDA-compliant compounding pharmacy using domestic APIs with documented chain of custody. Prescription required. Highest level of quality assurance available.
Tier 2, Gray Market / RUOSold as Research Use Only. May be synthesized to molecular standards, but has not gone through FDA approval. Chain of custody for the API is often unverifiable. A significant portion originates from Chinese manufacturing facilities, not inherently dangerous, but impossible to independently audit. Third-party COA from a reputable independent lab is the primary quality signal available to buyers.
Tier 3, Animal Data Only / No Human Trial HistoryCompounds that have never been in a human clinical trial for the claimed use. The biological rationale may be sound. The human evidence does not exist yet.
The RUO Reality

A Legal Posture, Not a Safety Rating

"Research Use Only" tells you about how a compound is classified legally. It does not tell you whether it's safe for human use. Some RUO compounds have extensive human research behind them and are registered pharmaceuticals in other countries. Others have never been in a human being.

When you see "RUO" on a supplier's website, the question to ask is not "is this safe because it's labeled for research?" The question is: what does the actual evidence trail look like for this specific compound, and where does it sit in the sourcing tier hierarchy?

That's what Peptide You is here to help you answer.

Cliff's Note

I built this framework because I needed it myself. Before I put anything in my body, I want to know two things: how far has the evidence traveled, and how verifiable is the quality of what I'm actually getting? Those are the two questions that matter. The rest is marketing.

Sources & Citations

  1. U.S. Food & Drug Administration. The Drug Development Process. fda.gov/patients/drug-development-process
  2. U.S. Food & Drug Administration. Current Good Manufacturing Practice (CGMP) Regulations. fda.gov/drugs/pharmaceutical-quality-resources/cgmp-regulations
  3. U.S. Food & Drug Administration. 503B Outsourcing Facilities. fda.gov/drugs/human-drug-compounding/503b-outsourcing-facilities